AlphaFold predicted structure
RNASEH1 · O60930

Mean pLDDT
79.6/ 100
Confident
286 residues
Confidence breakdown
- Very high(≥ 90)63%
- Confident(70–90)10%
- Low(50–70)3%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ribonuclease H1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalMitochondrial DNA maintenance disorder
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2
adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
hereditary disease
non-small cell lung carcinoma
viral infectious disease
cancer
restless legs syndrome
infection
movement disorder
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ribonuclease H1
Endonuclease that specifically degrades the RNA of RNA-DNA hybrids (PubMed:10497183). Plays a role in RNA polymerase II (RNAp II) transcription termination by degrading R-loop RNA-DNA hybrid formation at G-rich pause sites located downstream of the poly(A) site and behind the elongating RNAp II (PubMed:21700224)
RNASEH1 · O60930

Mean pLDDT
79.6/ 100
Confident
286 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0